Thanks for posting ablm,
He's an impressive man is Baker. The clowns running the webinar left out a couple of slides from his deck and he bounced back very well, always considered that trait as being indicative of someone that knows their game.
Interesting to see the latest CAR-T deal (Dec of 23) where Astrazeneka swallowed Gracell for 1.2 billion at Ph1b.
So ALA is (potentially) a global front runner in the cell therapy manufacturing space and has an opportunity for FDA platform designation. I continue to maintain that this achievement has significantly ignored or misunderstood by the market.
Below is a link is the final of a 4-part series on Cell Therapy which identifies risks and (interestingly) the CAR-T pivot from cancers to autoimmune disease
https://www.fiercebiotech.com/biotech/cell-therapy-reckoning-how-get-cell-therapies-flying-shelf
![]()
Finally, can't see the results from Ph1 trial being available until Q1,25 although the weekly Heikin Ashi chart looks good.
![]()
- Forums
- ASX - By Stock
- ALA
- Breakout Looming?
Breakout Looming?, page-387
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ALA (ASX) to my watchlist
|
|||||
Last
14.5¢ |
Change
0.005(3.57%) |
Mkt cap ! $152.5M |
Open | High | Low | Value | Volume |
14.5¢ | 14.5¢ | 14.0¢ | $47.52K | 327.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 7168 | 14.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
15.0¢ | 374430 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 7168 | 0.145 |
9 | 751247 | 0.140 |
12 | 517292 | 0.135 |
8 | 367615 | 0.130 |
8 | 531775 | 0.125 |
Price($) | Vol. | No. |
---|---|---|
0.150 | 374430 | 9 |
0.155 | 283486 | 4 |
0.160 | 320250 | 7 |
0.165 | 550062 | 6 |
0.170 | 289489 | 6 |
Last trade - 15.39pm 23/08/2024 (20 minute delay) ? |
Featured News
ALA (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online